Conference: AAIC 2026 | Dates: July 12-15, 2026 | Location: Excel London, UK
AAIC 2026 features extensive research on lifestyle factors and modifiable risk factors for Alzheimer's disease prevention. This research builds on the 2024 Lancet Commission report identifying 14 modifiable risk factors that account for approximately 45% of dementia cases worldwide[1].
The 2024 Lancet Commission update identified 14 modifiable risk factors across the life course[1:1]:
| Life Stage | Risk Factors |
|---|---|
| Early Life (<45 years) | Less education, Hearing loss |
| Midlife (45-65 years) | High LDL cholesterol, Traumatic brain injury, Hypertension, Excessive alcohol, Obesity, Physical inactivity |
| Later Life (>65 years) | Smoking, Depression, Social isolation, Air pollution, Diabetes, Vision loss |
See full details at: Modifiable Risk Factors for Dementia
The landmark FINGER trial demonstrated that a 2-year multidomain intervention (diet, exercise, cognitive training, vascular risk monitoring) improved cognitive performance by 25% relative to controls in at-risk older adults[2].
Key Findings from AAIC 2026:
Intervention Components:
The SPRINT-MIND trial evaluated intensive blood pressure control (target systolic <120 mmHg) versus standard control (target systolic <140 mmHg)[4].
Key Findings:
Relevance to AD Prevention:
The PERSUADED (Polyunsaturated Fatty Acid Supplementation) trial examined whether omega-3 fatty acid supplementation can slow cognitive decline in older adults at risk for AD[5].
Key Findings from AAIC 2026:
The Mediterranean diet emphasizes:
Research presented at AAIC 2026 demonstrates:
The MIND (Mediterranean-DASH Intervention for Neurodegenerative Delay) diet combines elements of Mediterranean and DASH diets with a focus on brain-healthy foods:
Evidence presented at AAIC 2026 shows:
Emerging research on ketogenic interventions:
See: Mediterranean Diet in Neurodegeneration, MIND Diet
AAIC 2026 featured significant research on aerobic exercise benefits:
Resistance training benefits:
Evidence supports combined aerobic and resistance training for optimal cognitive benefits.
See: Exercise Therapy in Neurodegeneration, Physical Exercise in Parkinson's Disease
Cognitive reserve—the brain's resilience to pathological damage—is built through:
AAIC 2026 Research Highlights:
See: Cognitive Reserve in Neurodegeneration
Emerging evidence links sleep quality to AD risk:
See: Circadian Rhythm Modulation
Social isolation is a major risk factor with 5% population attributable fraction:
The World-Wide FINGERS initiative has now expanded to 46+ countries[3:1]:
AAIC 2026 featured research on personalized prevention strategies:
Based on AAIC 2026 findings:
Livingston G, et al. Dementia prevention, intervention, and care: 2024 Lancet Commission. Lancet. 2024. ↩︎ ↩︎
Kivipelto M, et al. FINGER trial: 10-year follow-up cognitive outcomes. Alzheimer's & Dementia. 2024. ↩︎
Solomon A, et al. World-Wide FINGERS: Global implementation of multidomain dementia prevention. Alzheimer's & Dementia. 2024. ↩︎ ↩︎
Williamson JD, et al. SPRINT-MIND: Intensive blood pressure control and cognitive outcomes. JAMA. 2024. ↩︎
Gardener SL, et al. PERSUADED: Polyunsaturated fatty acid supplementation and cognitive decline. Neurology. 2024. ↩︎